Press Releases

First-in-human clinical trial aims to treat neuroblastomaJun 15, 2018
In a promising development, researchers announced a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using genetically engineered natural killer T cells (NKTs).
Baylor endorses goal to eliminate HPV-related cancersJun 7, 2018
Baylor and each of the National Cancer Institute-designated cancer centers in issuing a joint statement in support of initiatives to eliminate cancers caused by the human papillomavirus (HPV).
DNA repair defect may drive some cancer treatment resistanceMay 25, 2018
Researchers found that defects in selective DNA damage repair pathways can drive endocrine treatment resistance in a subset of estrogen receptor positive breast cancer patients.
Researchers awarded multiple Department of Defense grants in next frontier of breast cancer genomicsMay 24, 2018
The Department of Defense has awarded researchers at Baylor College of Medicine multiple grants to help better understand breast cancer genomics.
Research challenges current mechanism of tumor formationMay 21, 2018
New evidence challenges a mechanism currently considered to contribute to tumor formation. 
Answers to 100-year-old mystery point to potential breast cancer therapiesApr 3, 2018
A team of researchers at Baylor College of Medicine and Roswell Park Comprehensive Cancer Center has identified a long sought after connection between how cancer cells use glucose to generate energy and cancer growth.
Potential new strategy to fight ovarian cancer foundMar 28, 2018
A new discovery opens the possibility of developing a novel way to fight ovarian cancer.
New promise found in treating triple negative breast cancerMar 26, 2018
A new study has identified a novel treatment strategy that may be effective for triple negative breast cancer patients.
Autoimmune disease treatments focus of McNair SymposiumMar 13, 2018
Dr. Jeffrey A. Bluestone, the A.W. and Mary Margaret Clausen Distinguished Professor at the University of California San Francisco, will be the Distinguished Lecturer at the Seventh Annual McNair Symposium at Baylor College of Medicine.
Baylor geneticists, oncologists host symposium in JapanMar 9, 2018
The Department of Molecular and Human Genetics and the Dan L Duncan Comprehensive Cancer Center  hosted their first joint U.S.-Japan Clinical Cancer Genomics and Personalized Medicine Symposium in Tokyo, Japan.
Maximizing nutrition during cancer careMar 6, 2018
The physical and emotional tolls chemotherapy can have on a patient undergoing cancer treatment are well known, but there are many myths when it comes to managing fitness and nutrition during treatment. Nutritionist Rachel Dudley explains.
Baylor College of Medicine awarded $3 million from CPRITFeb 26, 2018
Researchers at Baylor College of Medicine have received $3,568,639 from the Cancer Prevention and Research Institute of Texas for three new grants focused on tobacco control, cancer screening and novel treatments for cancer in children and adults
Baylor team shortlisted for Cancer Research UK grantsFeb 15, 2018
A multidisciplinary team of scientists has been shortlisted to the final stages of Cancer Research UK’s Grand Challenge, an ambitious series of £20 million global grants tackling some of the toughest questions in cancer research.
Classification can lead to new ways to diagnose, treat cancerFeb 12, 2018
A novel approach to studying cancer has enabled researchers to group about 10,000 human cancers of 32 different types into 10 classes based on the molecular pathways that drive tumor growth.
Immunotherapy summit brings together patients, expertsJan 11, 2018
The NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is hosting a free educational program for cancer patients and their caregivers seeking to learn more about cancer immunotherapy and clinical trials.
Research reveals path to ependymoma chemotherapyJan 4, 2018
Dr. Stephen Mack and colleagues have developed a framework for discovering targets in ependymomas, and other cancer that lack known genetic drivers, thereby also providing insights into treatment strategies.
G-quadruplex regulates breast cancer-associated geneDec 21, 2017
Researchers have now discovered a mechanism by which cells can regulate switching between the two proteins, opening options for the development of novel therapeutic strategies to control cancer growth in the future.
Dr. Jeffery Rosen honored for breast cancer research Dec 8, 2017
Dr. Jeffrey Rosen was awarded the American Association for Cancer Research (AACR) Distinguished Lecture in Breast Cancer Research at the San Antonio Breast Cancer Symposium.
Dr. Matthew Ellis named to Forbes’ “Physician Honor Roll"Dec 5, 2017
Dr. Matthew Ellis is one of 27 breast oncologists across the country being recognized by Forbes as an exemplary physician in the field of breast cancer oncology.
Dr. Trey Westbrook named new McNair ScholarDec 5, 2017
Dr. Trey Westbrook has been named the newest McNair Scholar. This recognition will support his work focused on discovering the genes and mechanisms that drive breast cancer and developing the next generation of cancer medicines.